Canada markets closed

MedX Health Corp (MDX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1200-0.0050 (-4.00%)
At close: 3:26PM EDT
Full screen
Previous Close0.1250
Open0.1250
Bid0.1150 x N/A
Ask0.1200 x N/A
Day's Range0.1200 - 0.1250
52 Week Range0.0700 - 0.1600
Volume53,100
Avg. Volume146,822
Market Cap21.051M
Beta (5Y Monthly)-0.11
PE Ratio (TTM)N/A
EPS (TTM)-0.0230
Earnings DateAug. 28, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.45
  • MedX Health Corp. Announces Management Changes and Increased Focus on SIAscopy™ on DermSecure™
    Business Wire

    MedX Health Corp. Announces Management Changes and Increased Focus on SIAscopy™ on DermSecure™

    MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) announced that it has completed management changes to enhance its focus on its dermatological services and products ("DSP") including DermSecure™ and SIAscopy™.

  • MedX Health Corp. Announces Postponement of the Release of Second Quarter Interim Financial Statements and Related Disclosure Due to COVID-19 Related Delays
    Business Wire

    MedX Health Corp. Announces Postponement of the Release of Second Quarter Interim Financial Statements and Related Disclosure Due to COVID-19 Related Delays

    MedX Health Corp. (MDX: TSXV) ("the Company"), announces that there will be a delay in the filing of its Interim Financial Statements and accompanying Management’s Discussion and Analysis, and related CEO and CFO certifications for the Second Quarter ended June 30, 2020 (collectively "Interim Filings") due to COVID-19 related delays.

  • MedX Announces Issuance of Shares in Connection with Advertising Services Agreement
    Business Wire

    MedX Announces Issuance of Shares in Connection with Advertising Services Agreement

    MedX Health Corp. ("MedX") (TSX-V: MDX) announces that pursuant the agreement for an online marketing and awareness program through AGORACOM, that was announced in a Press Release dated June 1, 2020, it has settled the second payment to AGORACOM, in the amount of $13,560, by issuance on August 12, 2020, of 104,307 shares at an issue price of $0.13 per share. The issue price of the shares was determined by using the undiscounted closing price of the Shares of the Company on the TSX Venture Exchange on August 11, 2020, being the last trading day before the date of issuance. The shares were issued pursuant to the prospectus exemption contained in section 2.24 of National Instrument 45-106 Prospectus Exemptions, and are not subject to trading restrictions pursuant to the provisions of National Instrument 45-102, Resale of Securities since the criteria contained in NI 45-102 2.6(3) are met.